Skip to main content

Table 2 Univariate and injury severity score-adjusted models for the combined outcome

From: The potential utility of urinary biomarkers for risk prediction in combat casualties: a prospective observational cohort study

Marker

Univariate

Adjusted for ISS

 

OR (95 % CI)

P value

AUC

OR (95 % CI)

P value

CyC

2.19 (1.48, 3.26)

<0.001

0.815

1.97 (1.26, 3.10)

0.003

IL-18

1.68 (1.13, 2.49)

0.01

0.682

1.45 (0.96, 2.20)

0.08

KIM-1

0.85 (0.50, 1.44)

0.54

0.549

0.61 (0.31, 1.18)

0.14

LFABP

2.13 (1.41, 3.22)

<0.001

0.842

1.92 (1.24, 2.99)

0.004

NGAL

1.96 (1.37, 2.81)

<0.001

0.820

1.80 (1.21, 2.66)

0.004

ISS

1.05 (1.02, 1.08)

0.002

0.790

-

-

  1. Odds ratio (OR) represents per one log increase in biomarker-to-creatinine ratio and one unit increase in injury severity score. CyC cystatin C, IL-18 interleukin-18, KIM-1, kidney injury molecule-1, L-FABP liver-type fatty acid-binding protein, NGAL neutrophil gelatinase-associated lipocalin, ISS, injury severity score